← Back to Search

Behavioral Intervention

ASSIST Program for Autism Spectrum Disorder (ASSIST Trial)

N/A

Waitlist Available

Led By Julie Lounds Taylor, PhD

Research Sponsored by Vanderbilt University Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 6-month, baseline to 12-month, baseline to 24-month, and baseline to 30-month post intervention

Awards & highlights

ASSIST Trial Summary

This trial is testing a parent intervention training program to see if it improves the transition to adulthood for youth with ASD. The current intervention has been paused due to COVID-19, but the trial is still recruiting participants.

Who is the study for?

This trial is for parents living in TN, IL, or WI with a child aged 16-26 diagnosed with Autism Spectrum Disorder (ASD). Parents must be English-speaking and willing to attend weekly web-conferencing sessions. They should agree to random assignment to either the treatment or control group and be able to participate in remote data collection.Check my eligibility

What is being tested?

The ASSIST program is being tested as an intervention training for parents. It aims to improve their ability to advocate for services that facilitate the transition into adulthood for youth with ASD. The study was adapted due to COVID-19 restrictions and now uses web-conferencing instead of in-person meetings.See study design

What are the potential side effects?

Since ASSIST is an educational intervention rather than a medical treatment, it does not have physical side effects. However, participants may experience stress or frustration related to learning new advocacy skills or from technical issues during online sessions.

ASSIST Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 6-month, baseline to 12-month, baseline to 24-month, and baseline to 30-month post intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 6-month, baseline to 12-month, baseline to 24-month, and baseline to 30-month post intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 6-month, baseline to 12-month, baseline to 24-month, and baseline to 30-month post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Access to Services Interview: Number of services the family applied for

Change in Access to Services Interview: Number of services the family is receiving

Post-Secondary Youth Outcomes

+3 more

Secondary outcome measures

Change in Access to Services Interview: Barriers to service receipt

Change in Access to Services Interview: Unmet service needs

Change in Advocacy Skills and Comfort Scale

+8 more

Other outcome measures

Change in Access to Services interview: Number of services the family applied for

Change in Access to Services interview: Number of services the family is receiving

Change in Advocacy Activities Scale

+1 more

ASSIST Trial Design

2Treatment groups

Experimental Treatment

Group I: Control: Written materials only groupExperimental Treatment1 Intervention

This informational control group will receive the ASSIST binder and all written materials developed for the program on the same schedule as the treatment group but will not attend the group sessions. After the treatment group is treated and follow up data is collected for comparison between treatment and control, the control group will have the option to take the ASSIST training program.

Group II: ASSIST intervention groupExperimental Treatment1 Intervention

This group will attend the 12 sessions of the ASSIST training program (one 2-hour session per week for 12 weeks).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

ASSIST

2016

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Illinois at Urbana-ChampaignOTHER

188 Previous Clinical Trials

37,155 Total Patients Enrolled

1 Trials studying Autism Spectrum Disorder

55 Patients Enrolled for Autism Spectrum Disorder

Vanderbilt University Medical CenterLead Sponsor

856 Previous Clinical Trials

672,012 Total Patients Enrolled

15 Trials studying Autism Spectrum Disorder

2,330 Patients Enrolled for Autism Spectrum Disorder

University of Wisconsin, MadisonOTHER

1,182 Previous Clinical Trials

3,167,207 Total Patients Enrolled

8 Trials studying Autism Spectrum Disorder

801 Patients Enrolled for Autism Spectrum Disorder

Media Library

ASSIST (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04173663 — N/A

Autism Spectrum Disorder Research Study Groups: ASSIST intervention group, Control: Written materials only group

Autism Spectrum Disorder Clinical Trial 2023: ASSIST Highlights & Side Effects. Trial Name: NCT04173663 — N/A

ASSIST (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04173663 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for prospective participants of this clinical trial?

"The protocol listed on clinicaltrials.gov confirms that this study is not currently seeking participants; initially posted 1/3/2020 and most recently updated 9/6/2022. Fortunately, there are 280 other trials in need of volunteers at the present time."

Answered by AI